Literature DB >> 14712075

To be or not to be ubiquitinated?

Joanna Bloom1, Michele Pagano.   

Abstract

Levels of p21, a cyclin-dependent kinase (CDK) inhibitor, are controlled in part at the post-translational level by protein degradation. Although the signaling pathways leading to p21 degradation have not yet been fully elucidated, it is evident that p21 ubiquitination is an essential factor in its degradation. We discuss that, with the only notable exception of ornithine decarboxylase, ubiquitination appears to be a prerequisite for proteasomal degradation rather than an unnecessary byproduct of such proteolysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712075

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

1.  APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.

Authors:  Virginia Amador; Sheng Ge; Patricia G Santamaría; Daniele Guardavaccaro; Michele Pagano
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

2.  p21(Cip1) expression is increased in ambient oxygen, compared to estimated physiological (5%) levels in rat muscle precursor cell culture.

Authors:  S J Lees; T E Childs; F W Booth
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

3.  The nanny model for IDPs.

Authors:  Peter Tsvetkov; Nina Reuven; Yosef Shaul
Journal:  Nat Chem Biol       Date:  2009-11       Impact factor: 15.040

4.  Grape seed extract upregulates p21 (Cip1) through redox-mediated activation of ERK1/2 and posttranscriptional regulation leading to cell cycle arrest in colon carcinoma HT29 cells.

Authors:  Manjinder Kaur; Alpna Tyagi; Rana P Singh; Robert A Sclafani; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

5.  Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.

Authors:  Ioannis A Voutsadakis; Anna Patrikidou; Konstantinos Tsapakidis; Aristea Karagiannaki; Eleana Hatzidaki; Nikolaos E Stathakis; Christos N Papandreou
Journal:  Int J Colorectal Dis       Date:  2010-04-16       Impact factor: 2.571

6.  N-terminal polyubiquitination and degradation of the Arf tumor suppressor.

Authors:  Mei-Ling Kuo; Willem den Besten; David Bertwistle; Martine F Roussel; Charles J Sherr
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

7.  Treatment of PC12 cells with nerve growth factor induces proteasomal degradation of T-cadherin that requires tyrosine phosphorylation of its cadherin domain.

Authors:  Shoumei Bai; Jharna Datta; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2007-07-13       Impact factor: 5.157

8.  Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest.

Authors:  Annika Järviluoma; Emma S Child; Grzegorz Sarek; Papinya Sirimongkolkasem; Gordon Peters; Päivi M Ojala; David J Mann
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

9.  Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the  receptor protein of CRL2Prame complex.

Authors:  Wenjuan Zhang; Lihui Li; Lili Cai; Yupei Liang; Junfeng Xu; Yue Liu; Lisha Zhou; Chen Ding; Yanmei Zhang; Hu Zhao; Jun Qin; Zhimin Shao; Wenyi Wei; Lijun Jia
Journal:  Cell Death Differ       Date:  2021-01-27       Impact factor: 15.828

10.  Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation.

Authors:  Antonio Bilancio; Paola Bontempo; Marzia Di Donato; Mariarosaria Conte; Pia Giovannelli; Lucia Altucci; Antimo Migliaccio; Gabriella Castoria
Journal:  Oncotarget       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.